Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
How America lost control of bird flu, setting the stage for another pandemic
Long listed among pathogens with pandemic potential, H5N1’s unprecedented spread among cows marked a worrying shift ...
Trump looks to withdraw from WHO on first day of his administration after calling the health body a puppet of Beijing for failing to hold China accountable for COVID
Donald Trump initiated the year-long withdrawal process from the WHO in 2020 but six months later his successor, President ...
FDA says the Zepbound shortage is over. Here's what that means for compounding pharmacies, patients who used off-brand versions
The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.
EURACTIV19h
Trump transition team plans immediate WHO withdrawal, expert says
Lawrence Gostin, professor of global health at Georgetown University in Washington said that Trump planned to exit WHO from ...
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...
US FDA approves Hikma's generic version of Novo's diabetes drug Victoza
The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...
US FDA revokes authorization for four COVID antibody drugs
The U.S. Food and Drug Administration has revoked the emergency use authorization for four COVID-19 antibody-based drugs, ...
Vertex wins approval for new once-daily CF drug
Vertex Pharmaceuticals Inc. notched two FDA victories late Friday for its cystic fibrosis medicines, increasing the number of ...